Evidence map›Paper›PMID 33608608›Full record

ArticleScientific reports2021

Extracts of select endemic plants from the Republic of Mauritius exhibiting anti-cancer and immunomodulatory properties.

Shahin Kauroo, Joyce Govinden-Soulange, V Mala Ranghoo-Sanmukhiya, Kathryn Miranda, William E Cotham, Michael D Walla, Mitzi Nagarkatti, Prakash Nagarkatti

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Nutraceutical Potential ofMolecules (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Phytochemicals as Immunomodulatory Agents in Melanoma.International journal of molecular sciences · 2023
    Review
  5. Bioengineered · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shahin KaurooFaculty of Agriculture, University of Mauritius, Reduit, Moka, Republic of Mauritius.
Joyce Govinden-SoulangeFaculty of Agriculture, University of Mauritius, Reduit, Moka, Republic of Mauritius.
V Mala Ranghoo-SanmukhiyaFaculty of Agriculture, University of Mauritius, Reduit, Moka, Republic of Mauritius.
Kathryn MirandaDepartment of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, 202 Osborne Administration Building, Columbia, SC, 29208, USA.
William E CothamDepartment of Chemistry and Biochemistry, College of Arts and Science, University of South Carolina, Columbia, SC, USA.
Michael D WallaDepartment of Chemistry and Biochemistry, College of Arts and Science, University of South Carolina, Columbia, SC, USA.
Mitzi NagarkattiDepartment of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, 202 Osborne Administration Building, Columbia, SC, 29208, USA.
Prakash NagarkattiDepartment of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, 202 Osborne Administration Building, Columbia, SC, 29208, USA. prakash@mailbox.sc.edu.

Funding

Targeting early ceramide elevation in pre-symptomatic eczemaP20GM103641 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ENOS, REILLY, NAGARKATTI, PRAKASH S · 2012 to 2023
$20.7M
Use of Resveratrol to treat experimental multiple sclerosisP01AT003961 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, PRAKASH S · 2007 to 2018
$14.2M
Epigenetic Mechanisms of T Cell Dysregulation in PTSDR01AI129788 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI · 2017 to 2021
$2.4M
AhR ligands in epigenetic dysregulation of T cellsR01AI123947 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2017 to 2021
$1.8M
NCCIH NIH HHS P01 AT003961NIAID NIH HHS R01 AI123947NIAID NIH HHS R01 AI129788NIGMS NIH HHS P20 GM103641NIH HHS P01AT003961NIH HHS P20GM103641NIH HHS R01AI123947NIH HHS R01AI129788
6 · The paper itself

Abstract

Mauritius Island possesses unique plant biodiversity with a potential reservoir of biologically active compounds of pharmacological interest. In the current study, we investigated Mauritius endemic plant families Asteraceae, Ebenaceae, Sapotaceae, and Erythroxylaceae, for anti-cancer properties on T cell lymphoma and B16F10 Melanoma cells and immunomodulatory properties on primary T and B cells. The cytotoxicity of methanolic plant extracts at 1, 10, 25 µg/ml was determined. The most active plant species were evaluated for their apoptosis-inducing effects. The immunomodulatory properties of the plants were also studied, and preliminary phytochemical screening of selected plants was done by LC-MS analysis. Psiadia lithospermifolia (Lam.) Cordem (Asteraceae) at 25 µg/ml was the most cytotoxic on both EL4 and B16 cells and triggered apoptosis by the death receptor pathway, and at least in part, by the mitochondrial pathway. Most plant species from Asteraceae, Ebenaceae, Erythroxylaceae, and Sapotaceae inhibited the proliferation of activated T and B cells, although some promoted T cell proliferation. LC-MS profile of Asteraceae plants showed the presence of terpenes, terpenoids, fatty acids, and phenolic. Flavonoids and phenolic acid were also detected from Ebenaceae and Sapotaceae plants. Together, our study demonstrated that Mauritius endemic flora exhibit potential anti-cancer and anti-inflammatory properties worthy of further in-depth studies.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCell LineCell SurvivalChromatography, High Pressure LiquidDrug DiscoveryFemaleImmunologic FactorsLymphocytesMauritiusMelanoma, ExperimentalMembrane Potential, MitochondrialMicePlant ExtractsPlant LeavesAntineoplastic Agents, PhytogenicImmunologic FactorsPlant Extracts

Identifiers

PMID33608608
PMCPMC7895923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.